Subscribe to MDT Magazine News

Taris Biomedical rounds up $18.3M in Series B financing

April 13, 2011 5:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Taris Biomedical, a Lexington life sciences company developing combination drug-device products and co-founded by Michael Cima and Robert Langer, has taken in $18.3 million in a Series B funding round led by new investor Third Rock Ventures.


GE Healthcare Presents Interim Data on the Impact of DaTscanâ„¢ (Ioflupane I 123 Injection) SPECT Imaging on the Diagnosis and Clinical Management of Patients with Clinically Un...

April 13, 2011 5:33 am | by Bio-Medicine.Org | Comments

HONOLULU, April 13, 2011 /- Today, GE Healthcare announced interim results of a recently completed randomized study of the impact of DaTscan™ SPECT imaging on the clinical  management and diagnosis of adult patients who exhibit signs or symptoms of parkinsonian syndromes (PS)....


Medyssey Spine Receives 510(k) Clearance for Its LP Cage(TM) Posterior Lumbar Interbody Fusion System

April 13, 2011 3:37 am | by Bio-Medicine.Org | Comments

CHICAGO, April 13, 2011 /- Medyssey Co., Ltd., the parent company of Medyssey Spine , a spinal implant manufacturer focused on commercializing products for the surgical treatment of spine disorders, today announced that the Company has received 510(k) clearance from the FDA for its LP...


According to the Journal of Advanced Nursing, RyMed Technologies' InVision-Plus® Excels at Minimizing Bacterial Growth In Vitro

April 13, 2011 3:34 am | by Bio-Medicine.Org | Comments

FRANKLIN, Tenn., April 13, 2011 /- In the Journal of Advanced Nursing March issue, a comparative research evaluation of five needleless I.V. connectors tested by an independent laboratory showed that the RyMed InVision-Plus® (RYM-5001®) zero displacement connector best protected...


Mass. state agencies, local companies shoot to make a splash at BIO show

April 12, 2011 8:41 pm | by Mass High Tech: The Journal of New England Technology | Comments

Massachusetts state officials, industry groups, life sciences companies and educational institutions will have a dual purpose when they go to the BIO International Convention in Washington, D.C., in June. They will be promoting the 2012 version of BIO, which will be returning to Boston,...


Speeding Up the Healing Process

April 12, 2011 8:39 pm | by Massachusetts Institute of Technology | Comments

New agents could help the body repair chronic wounds, and make the normal healing process work more quickly.

Investigational Drug May Reduce Involuntary Movements in People With Parkinson's Disease

April 12, 2011 12:36 pm | by Bio-Medicine.Org | Comments

HONOLULU, April 12, 2011 /PRNewswire-USNewswire/ -- Results of the first randomized, placebo-controlled long-term clinical trial show the investigational drug safinamide may reduce dyskinesia or involuntary movements in mid-to-late stage Parkinson's disease. The findings will be presented...


Changing trends in hip fracture incidence around the world

April 12, 2011 11:42 am | by EurekAlert | Comments

(International Osteoporosis Foundation) A review by a scientific working group of the IOF shows that age-specific hip fracture rates have changed during recent decades -- decreasing in some countries or regions while increasing in others. The review examines some possible reasons...


BioScale scales up with new MEMS sensor fab cleanrooms, HQ

April 12, 2011 11:41 am | by I-Micronews | Comments

BioScale Inc., a life science company that develops, manufactures, and promotes novel analytical tools enabling advancements in protein research, relocated its corporate headquarters to 4 Maguire Road in Lexington, MA.

Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin

April 12, 2011 11:36 am | by Bio-Medicine.Org | Comments

EAST HANOVER, N.J., April 12, 2011 /- Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval of Afinitor® (everolimus) tablets for the treatment of patients with...


MSA Schedules First Quarter Earnings Webcast

April 12, 2011 11:35 am | by Bio-Medicine.Org | Comments

PITTSBURGH, April 12, 2011 /- MSA (NYSE: MSA ), the global leader in the development, manufacture and supply of products that protect people's health and safety, announced today that it will broadcast a first quarter 2011 earnings conference call live via the Internet on Thursday, April...


Biotech and cystic fibrosis: A kid's view

April 12, 2011 10:42 am | by Mass High Tech: The Journal of New England Technology | Comments

The star of the show was an 8-year-old Red Sox fan from Dedham named Bobby Coughlin, not the 200 globe-trotting investors and accomplished life sciences executives who were both the attendees and speakers at the Boston Biotech Conference. He sat with his father, MassBio president and CEO...

Concert Pharmaceuticals names Roessel, Sabounjian to exec roles

April 12, 2011 10:42 am | by Mass High Tech: The Journal of New England Technology | Comments

Concert Pharmaceuticals Inc. has made two new executive appointments to grow its development work. Mark Roessel has been named vice president of regulatory affairs and quality assurance, while LuAnn Sabounjian has been appointed vice president of clinical operations.

Consumer thrift on health care could help insurers

April 12, 2011 9:45 am | by The Associated Press | Comments

Managed health care companies will likely report upbeat first-quarter financial results, as consumers continue to cut spending on medical visits in a recovering economy, according to a Wedbush analyst Tuesday.Several insurers benefited from that trend throughout the third and fourth quarters,...

Montana Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program

April 12, 2011 9:36 am | by Bio-Medicine.Org | Comments

HELENA, Mont., April 12, 2011 /PRNewswire-USNewswire/ -- The association representing Montana's providers of home medical equipment and services supports a new, bipartisan bill in Congress to repeal the controversial Medicare "competitive" bidding program for home medical equipment and...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.